Cas 455917-34-7,Methane Sulfonic Acid-4-aminomethyl-1-benzyl-pyrrolidine-3-yl Ester

455917-34-7

Post Buying Request

Basic information

Product Name: Methane Sulfonic Acid-4-aminomethyl-1-benzyl-pyrrolidine-3-yl Ester
Synonyms: Methane Sulfonic Acid-4-aminomethyl-1-benzyl-pyrrolidine-3-yl Ester
CAS NO:455917-34-7
Molecular Formula:
Molecular Weight: 284.379
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Methane Sulfonic Acid-4-aminomethyl-1-benzyl-pyrrolidine-3-yl Ester(CAS DataBase Reference)
NIST Chemistry Reference: Methane Sulfonic Acid-4-aminomethyl-1-benzyl-pyrrolidine-3-yl Ester(455917-34-7)
EPA Substance Registry System: Methane Sulfonic Acid-4-aminomethyl-1-benzyl-pyrrolidine-3-yl Ester(455917-34-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 455917-34-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

455917-34-7 Suppliers

Recommended suppliers

455917-34-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 455917-34-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,5,5,9,1 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 455917-34:
(8*4)+(7*5)+(6*5)+(5*9)+(4*1)+(3*7)+(2*3)+(1*4)=177
177 % 10 = 7
So 455917-34-7 is a valid CAS Registry Number.

455917-34-7Upstream product

455917-34-7Downstream Products

134253-05-7 3-benzyl-3,6-diazabicyclo [3.2.0] Heptane

455917-34-7Relevant academic research and scientific papers

Modulators of chemokine receptor activity

-

, (2008/06/13)

Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation are described herein.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 455917-34-7